Results 201 to 210 of about 1,060,485 (284)
Pegcetacoplan as a targeted C3 inhibitor in C3 glomerulopathy and immune-complex MPGN. [PDF]
Habib E, Hajj F.
europepmc +1 more source
ABSTRACT Innovative legislation aspires for an extra‐jurisdictional effect on modern slavery in supply chains through increased transparency. Evidence to date suggests that firms are not rising to this challenge, and, if anything, mandatory reporting practices are coalescing around superficial reports decoupled from policy objectives. To decide how the
Bruce Pinnington +1 more
wiley +1 more source
Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk. [PDF]
Vahldieck C, Fels B.
europepmc +1 more source
A Genetically Encoded Marker for Imaging of Internal Plasmodium Membranes
IMMP is a peptide‐based marker that labels internal membranes across multiple stages and species of the malaria‐causing parasite Plasmodium. It works in both live and fixed samples and supports long‐term live‐cell imaging. ABSTRACT Fluorescence microscopy is a powerful tool to analyze the subcellular architecture, and long‐term live‐cell imaging ...
Leah Zink +9 more
wiley +1 more source
Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature review. [PDF]
Gan KX +5 more
europepmc +1 more source
ABSTRACT Aim The objective of this study was to investigate the global profile of plasmatic proteins of individuals affected simultaneously or not by type 2 diabetes mellitus (T2DM, well/poorly‐controlled), Dyslipidemia (DL), and Periodontitis (P). Methods Besides periodontal examination, plasma was collected for glycemic, and lipid analyses from 150 ...
François Isnaldo Dias Caldeira +7 more
wiley +1 more source
Clinical Course After a Single Cycle of Rozanolixizumab in Generalized Late-Onset Myasthenia Gravis. [PDF]
Aritake S, Nagai A.
europepmc +1 more source
This graphical abstract illustrates our systematic site‐saturation mutagenesis at the Ser118 position of the AM1_1499g1 GAF domain. By replacing this single residue, we generated a diverse array of variants with distinct spectral properties, demonstrating the remarkable molecular plasticity of cyanobacteriochromes and their customizability for ...
A. Yoneda, T. Suzuki, R. Narikawa
wiley +1 more source
Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and Hurdles. [PDF]
Mannes M, Zelek WM, Trouw LA.
europepmc +1 more source
Abstract Background Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic stem cell disorder caused by somatic mutations in the PIGA gene, resulting in loss of glycosylphosphatidylinositol (GPI)‐anchored proteins, including the complement regulatory proteins, CD55 and CD59.
Ganesh Raman +4 more
wiley +1 more source

